Monday, November 2nd, 2009
The U.S. Food and Drug Administration (FDA) announced Oct. 23, in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
Monday, November 2nd, 2009
If you’re confused about carrier rules for coding H1N1 vaccines, you’re not alone. Choosing H1N1 codes in regard to Medicare and private insurance guidelines, and when to use a modifier can leave you dumbfounded. To answer your H1N1 questions, here’s the low-down on Medicare policies vs. private insurer policies.
Monday, November 2nd, 2009
The Centers for Medicare & Medicaid Services (CMS) updated, Oct. 14, its Medicare Fee-for-Service (FFS) Q&As to address H1N1-related questions circling among the health care industry. Read more »
Copyright © 2009 American Academy of Professional Coders | 2480 South 3850 West, Suite B, Salt Lake City, Utah 84120